This project explores the use of tumour targeting bacteria that convert non-toxic drugs into potent anticancer agents specifically within the tumour.
This work will lead to new cancer treatments that do not cause the severe side-effects associated with many other traditional cancer therapies.
Annual Lay Report
2010 - 2012
Prof Julian Rood, Prof Martin Brown, Dr Glen Carter
Cancer Council Research Grant
Department of Microbiology, Monash University
$96,250 per annum